Showing 1,461 - 1,480 results of 12,390 for search '"infection"', query time: 0.11s Refine Results
  1. 1461

    Modelling the immunopathogenesis of HIV-1 infection and the effect of multidrug therapy: The role of fusion inhibitors in HAART by Gesham Magombedze, Winston Garira, Eddie Mwenje

    Published 2008-05-01
    “…There is currently tremendous effort being directed at developingpotent, highly active antiretroviral therapies that can effectively control HIV-1 infection without the need for continuous, lifelong use of these drugs. …”
    Get full text
    Article
  2. 1462
  3. 1463

    Exploring the interplay between Eimeria spp. infection and the host: understanding the dynamics of gut barrier function by Pan Chen, Mujeeb Ur Rehman, Yanfeng He, Aoyun Li, Fuchun Jian, Longxian Zhang, Shucheng Huang

    Published 2025-12-01
    “…Numerous studies have also revealed that Eimeria-infected animals experience slower bone growth rates, inferior meat quality, reduced egg production and quality, as well as impaired growth and development. …”
    Get full text
    Article
  4. 1464

    Innate Immune Effectors Play Essential Roles in Acute Respiratory Infection Caused by Klebsiella pneumoniae by Dong Liu, Zhifu Chen, Yue Yuan, Haiming Jing, Jintao Zou, Xiaoli Zhang, Xi Zeng, Weijun Zhang, Quanming Zou, Jinyong Zhang

    Published 2020-01-01
    “…However, the roles of these effectors are not clearly defined during Klebsiella pneumoniae (K. pneumoniae) respiratory infection. In the current study, we established an acute pneumonia model of K. pneumoniae respiratory infection in mice and confirmed that the injury was most severe 48 h post infection. …”
    Get full text
    Article
  5. 1465
  6. 1466

    PPARγ Expression and Function in Mycobacterial Infection: Roles in Lipid Metabolism, Immunity, and Bacterial Killing by Patricia E. Almeida, Alan Brito Carneiro, Adriana R. Silva, Patricia T. Bozza

    Published 2012-01-01
    “…Although the significance of peroxisome proliferator-activated receptor gamma (PPARγ) activation by mycobacteria is not fully understood, recent findings are beginning to uncover a critical role for PPARγ during mycobacterial infection. Here, we will review the molecular mechanisms that regulate PPARγ expression and function during mycobacterial infection. …”
    Get full text
    Article
  7. 1467

    A Descriptive Study of Nosocomial Infections in an Adult Intensive Care Unit in Fiji: 2011-12 by Keshni Naidu, Ilisapeci Nabose, Sharan Ram, Kerri Viney, Stephen M. Graham, Karen Bissell

    Published 2014-01-01
    “…Nosocomial infections in an intensive care unit (ICU) are common and associated with a high mortality but there are no published data from the Oceania region. …”
    Get full text
    Article
  8. 1468
  9. 1469

    Caring at the transition: success and financial barriers of fidaxomicin discharge prescriptions for inpatients with Clostridioides difficile infection by Ellen Earle, Jigar Mehta, Alexis Blecher, Matthew Shou Lun Lee

    Published 2025-01-01
    “…This retrospective cohort study evaluated the proportion of inpatients initiated and successfully discharged on fidaxomicin for Clostridioides difficile infection. Nearly, all patients (96.4%; 27/28) were able to obtain fidaxomicin to complete their treatment course, although there was variability in copays among patients with Medicare.…”
    Get full text
    Article
  10. 1470
  11. 1471

    Canadian Hepatitis C Look-Back Investigation to Detect Transmission from an Infected General Surgeon by Meenakshi Dawar, Tammy L Stuart, Lamont E Sweet, Anne M Neatby, Lewis P Abbott, Anton P Andonov, Tom Wong, Robert Gervais, Rob Stirling

    Published 2010-01-01
    “…BACKGROUND: In February 2007, a general surgeon in Charlottetown, Prince Edward Island, tested positive for hepatitis C virus (HCV). The surgeon’s infection onset date could not be determined; however, episodic hepatic enzyme elevations were first detected in November 2004 and again in February 2007. …”
    Get full text
    Article
  12. 1472

    Cardiovascular Risk Assessment: A Comparison of the Framingham, PROCAM, and DAD Equations in HIV-Infected Persons by Max Weyler Nery, Celina Maria Turchi Martelli, Erika Aparecida Silveira, Clarissa Alencar de Sousa, Marianne de Oliveira Falco, Aline de Cássia Oliveira de Castro, Jorge Tannus Esper, Luis Carlos Silva e Souza, Marília Dalva Turchi

    Published 2013-01-01
    “…This study aims to estimate the risk of cardiovascular disease (CVD) and to assess the agreement between the Framingham, Framingham with aggravating factors, PROCAM, and DAD equations in HIV-infected patients. A cross-sectional study was conducted in an outpatient centre in Brazil. 294 patients older than 19 years were enrolled. …”
    Get full text
    Article
  13. 1473
  14. 1474

    Systemic Candida parapsilosis Infection Model in Immunosuppressed ICR Mice and Assessing the Antifungal Efficiency of Fluconazole by Yu’e Wu, Fangui Min, Jinchun Pan, Jing Wang, Wen Yuan, Yu Zhang, Ren Huang, Lixin Zhang

    Published 2015-01-01
    “…This study was to establish a systemic C. parapsilosis infection model in immunosuppressed ICR mice induced by cyclophosphamide and evaluate the antifungal efficiency of fluconazole. …”
    Get full text
    Article
  15. 1475

    Bioclimatologie des infections cutanées mycosiques à Sfax (Centre-Est de la Tunisie) by Mounir Jarraya

    Published 2016-12-01
    “…The fungal infections are a major public health problem in Sfax (Central-East of Tunisia) because it affects a vulnerable population. …”
    Get full text
    Article
  16. 1476

    Hopf Bifurcation for a Model of HIV Infection of CD4+ T Cells with Virus Released Delay by Jun-Yuan Yang, Xiao-Yan Wang, Xue-Zhi Li

    Published 2011-01-01
    “…A viral model of HIV infection of CD4+ T-cells with virus released period is formulated, and the effect of this released period on the stability of the equilibria is investigated. …”
    Get full text
    Article
  17. 1477
  18. 1478
  19. 1479
  20. 1480

    Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China by Chengguang Hu, Guosheng Yuan, Junwei Liu, Huaping Huang, Yanyu Ren, Yinping Li, Xuefu Chen, Wei Li, Tao Wu, Hong Deng, Yanzhong Peng, Yong-Yuan Zhang, Yuanping Zhou

    Published 2018-01-01
    “…There is scarcity of data in literature regarding the treatment response to sofosbuvir- (SOF-) based therapies in Chinese patients with chronic Hepatitis C Virus (HCV) infection. The aim of this study was to evaluate the efficacy and safety of SOF-based regimens for chronic hepatitis C (CHC) patients without cirrhosis in a real-world setting in mainland China. …”
    Get full text
    Article